No profile data available.
Nanoform Finland Oyj (NANOFH.HE) is a healthcare company in the drug manufacturing contractors industry, based in Helsinki, Finland, with about 108 full-time employees.
It reported revenue of 3.55 million EUR for fiscal year 2025, up 27.7% from fiscal year 2024, and net income of -17.90 million EUR. Europe was its largest region in fiscal year 2025, with 56% of revenue. Its market capitalization was 66.20 million EUR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.
Nanoform Finland Oyj reported 3.55 million EUR in revenue for fiscal year 2025, up 27.7% from 2.78 million EUR in fiscal year 2024.
Europe: 56% of revenue by region in fiscal year 2025, followed by United States (30%).
66.20 million EUR as of October 9, 2026.